Karyopharm Therapeutics Inc.KPTINASDAQ
LOADING
|||
Switch Symbol:
Gross Profit Growth Under Pressure
Trending lower.
Left:
||||
Year-over-year gross profit growth rate
Latest
13.70%
Near historical average
Average (39q)
13.56%
Historical baseline
Range
High:238.35%
Low:-63.16%
CAGR
+1.7%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 13.70% |
| Q2 2025 | 28.43% |
| Q1 2025 | -1.70% |
| Q4 2024 | -22.07% |
| Q3 2024 | -9.09% |
| Q2 2024 | 32.44% |
| Q1 2024 | -3.27% |
| Q4 2023 | -8.30% |
| Q3 2023 | -3.54% |
| Q2 2023 | -2.58% |
| Q1 2023 | 17.77% |
| Q4 2022 | -9.82% |
| Q3 2022 | -9.23% |
| Q2 2022 | -16.23% |
| Q1 2022 | -63.16% |
| Q4 2021 | 238.35% |
| Q3 2021 | 72.86% |
| Q2 2021 | -3.87% |
| Q1 2021 | -34.42% |
| Q4 2020 | 62.95% |
| Q3 2020 | -36.91% |
| Q2 2020 | 91.22% |
| Q1 2020 | 3.69% |
| Q4 2019 | 37.62% |
| Q3 2019 | 171.29% |
| Q2 2019 | 54.99% |
| Q1 2019 | 2.24% |
| Q4 2018 | -6.90% |
| Q3 2018 | -45.67% |
| Q2 2018 | 20.68% |
| Q1 2018 | 5.94% |
| Q4 2017 | -31.95% |
| Q3 2017 | -9.17% |
| Q2 2017 | 3.74% |
| Q1 2017 | -16.44% |
| Q4 2016 | -3.93% |
| Q3 2016 | 19.07% |
| Q2 2016 | -12.50% |
| Q1 2016 | 9.33% |
| Q4 2015 | 7.00% |